EUVIMEDEUVIMED entdecken
Open Access

Development of CD44E/s dual-targeting DNA aptamer as nanoprobe to deliver treatment in hepatocellular carcinoma

Cario Wing-Sze Lo, Cecilia Ka Wing Chan, Jianqing Yu, Mian He, Chung Hang Jonathan Choi, James Yun Wong Lau, Nathalie Wong

Nanotheranostics · 2022 · 6 (2) · 161-174

DOI: 10.7150/ntno.62639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanotheranostics, 2022. Verfasst von Cario Wing-Sze Lo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery at Sir Y.K. Pao Center for Cancer, The Chinese University of Hong Kong, Shatin, Hong Kong, China. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aptamers, NucleotideCarcinoma, HepatocellularLiver NeoplasmsAnimalsCell ProliferationHumansTissue Distribution

Stichwörter der Autor:innen

CD44aptamerhepatocellular carcinomananoprobetargeted cancer therapy

Substanzen

Aptamers, Nucleotide

Autor:innen und Institutionen

  • Department of Surgery at Sir Y.K. Pao Center for Cancer, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
  • Department of Biomedical Engineering, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
  • Science Research Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China.
  • State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Shatin, Hong Kong, China.

Zitieren

APA

Lo, C. W., Chan, C. K. W., Yu, J., He, M., Choi, C. H. J., Lau, J. Y. W., & Wong, N. (2022). Development of CD44E/s dual-targeting DNA aptamer as nanoprobe to deliver treatment in hepatocellular carcinoma. Nanotheranostics, 6(2), 161-174. https://doi.org/10.7150/ntno.62639

Vancouver

Lo CW, Chan CKW, Yu J, He M, Choi CHJ, Lau JYW, et al. Development of CD44E/s dual-targeting DNA aptamer as nanoprobe to deliver treatment in hepatocellular carcinoma. Nanotheranostics. 2022;6(2):161-174. doi:10.7150/ntno.62639

BibTeX
@article{Lo2022,
  author = {Lo, Cario Wing-Sze and Chan, Cecilia Ka Wing and Yu, Jianqing and He, Mian and Choi, Chung Hang Jonathan and Lau, James Yun Wong and Wong, Nathalie},
  title = {Development of CD44E/s dual-targeting DNA aptamer as nanoprobe to deliver treatment in hepatocellular carcinoma},
  journal = {Nanotheranostics},
  year = {2022},
  volume = {6},
  number = {2},
  pages = {161--174},
  doi = {10.7150/ntno.62639}
}
Kostenlos starten →